Figure - PMC

Skip to main content

View full-text article in PMC

. Author manuscript; available in PMC: 2023 Jul 1.

Published in final edited form as: Lancet Oncol. 2022 Jun 14;23(7):910–918. doi: 10.1016/S1470-2045(22)00251-0

Figure 3. — A) Patients reporting functional erections (IIEF ≥24 or ≤4-point decrease) or moderate erectile function (IIEF ≥11) without a change in medication status. B) Patients reporting moderate erectile function whether or not medication was initiated. Patients who did not report IIEF ≥24 (n=43) at baseline are excluded. Black dots and solid line, mean; dotted lines, 95% confidence intervals. At each timepoint, values are given for the mean and 95% CI.

Figure 3. — A) Patients reporting functional erections (IIEF ≥24 or ≤4-point decrease) or moderate erectile function (IIEF ≥11) without a change in medication status. B) Patients reporting moderate erectile function whether or not medication was initiated. Patients who did not report IIEF ≥24 (n=43) at baseline are excluded. Black dots and solid line, mean; dotted lines, 95% confidence intervals. At each timepoint, values are given for the mean and 95% CI.